Respiratory telehealth house Respiri proposes changing its name to Vitasora – its third title tweak over one and a half ...
BNC-210 is under clinical development by Bionomics and currently in Phase III for Social Anxiety Disorder (SAD/Social Phobia). According to GlobalData, Phase III drugs for Social Anxiety Disorder (SAD ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果